Industry News

Stay in the know with ASTRO’s Corporate Members!
Staying up to date with ASTRO's Corporate Members has never been easier! Now ASTRO members can find press releases and announcements surrounding industry involved with radiation oncology on ASTRO’s new industry webpage.

October 30, 2024

Novocure Reports Third Quarter 2024 Financial Results

Novocure announced that the U.S. FDA has granted Breakthrough Device designation for the use of TTFields therapy for brain metastases from non-small cell lung cancer.

September 26, 2024

RICOH 3-D for Healthcare and Kallisio partner to enhance radiation oncology care with Stentra™ oral stent

EXTON, PA, September 26, 2024  Ricoh USA, Inc. and Kallisio today announced a strategic partnership to manufacture and distribute Stentra™, a 510(k)-cleared, patient-specific oral stent designed to improve radiation therapy for head and neck cancer (HNC) patients. Developed using technology exclusively licensed from MD Anderson Cancer Center, Stentra™ is engineered to protect healthy tissue by precisely displacing and immobilizing sensitive areas during treatment, allowing for more targeted and effective radiation delivery. This innovation is crucial in minimizing side effects and enhancing overall treatment outcomes. Read full press release.